'Benign' hypertensive nephrosclerosis

QJM: An International Journal of Medicine

Volumn 100, Issue 2, 2007, Pages 113-119

  Dasgupta, Indranil ^a   Porter, C ^b   Innes, A ^c   Burden, R ^b  

^a BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

^b NOTTINGHAM CITY HOSPITAL   (United Kingdom)

^c CROSSHOUSE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIASTOLIC BLOOD PRESSURE; DISEASE DURATION; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; HYPERTENSION; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NEPHROSCLEROSIS; PREDICTION; PRIORITY JOURNAL; PROTEINURIA; SURVIVAL RATE; SYSTOLIC BLOOD PRESSURE;

EID: 33847414458     PISSN: 14602725     EISSN: 14602393     Source Type: Journal    
DOI: 10.1093/qjmed/hcl139     Document Type: Article

References (30)

1. US Renal Data System. USRDS 2004 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2004.
2. ERA-EDTA Registry. ERA-EDTA Registry 2003 Annual Report. Amsterdam, Academic Medical Centre, 2005.
3. Meyrier A, Simon P. Nephroangiosclerosis and hypertension: Things are not as simple as you might think. Nephrol Dial Transplantation 1996; 11:2116-20.
4. Mountokalakis TD. The renal consequences of arterial hypertension. Kidney Int 1997; 51:1639-53.
5. Perera G. Hypertensive vascular disease: Description and natural history. J Chronic Dis 1955; 1:33-42.
6. Lindeman RD, Tobin JD, Shock NW. Association between blood pressure and rate of decline in renal function with age. Kidney Int 1984; 26:861-8.
7. Perneger TV, Nieto J, Whelton PC, Klag MJ, Comstock GW, Szeklo M. A prospective study of blood pressure and serum creatinine. JAMA 1993; 269:488-93.
8. Perry HM Jr, Miller JP, Fornoff JR, Sambhi MP, Rutan G, Moskowitz DW, Carmody SR. Early predictors of 15-year end-stage renal disease in hypertensive patients. Hypertension 1995; 25:587-94.
9. Shulman NB, Ford MD, Simon D, Langford HG, et al. Prognostic vlue of serum creatinine and effect of treatment of hypertension on renal function: Results from the Hypertension Detection and Follow-up Programme. Hypertension 1989; 13(suppl. 1):180-93.
10. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FI, Ford CL, Shulman NB, Stamier J. A prospective study of blood pressure and incidence of end-stage renal disease in 332 544 men. N Engl J Med 1996; 334:13-18.
11. Iseki K, Ikemiya Y, Fukiyama K. Blood pressure and risk of end-stage renal disease in a screened cohort. Kidney Int 1996; 49(suppl. 55):S69-71.
12. Zucchelli P, Zuccala A. Primary hypertension - how does it cause renal failure? Nephrol Dial Transplant 1994; 9:223-5.
13. Siewert-Delle A, Ljungman S, Andersson OK, Wilhelmsen L. Does treated hypertension lead to end-stage renal disease? A 20-year follow-up of the Primary Prevention Study in Goteberg, Sweden. Nephrol Dial Transplant 1998; 13:3084-90.
14. Siewert-Delle A. Long-term renal function in primary hypertension. An epidemiological study. Scand J Urol Nephrol Suppl 1999; 199:1-36.
15. Beevers DG, Lip GYH. Does non-malignant essential hypertension cause renal damage? A clinician's view. J Human Hypertens 1996; 10:695-9.
16. Innes A, Johnston PA, Morgan AG, Davison AM, Burden RP. Clinical features of benign hypertensive nephrosclerosis at time of renal biopsy. Q J Med 1993; 86:271-5.
17. Vikse BE, Aasaróød K, Bostad L, Iversen BM. Clinical prognostic factors in biopsy-proven benign nephrosclerosis. Nephrol Dial Transplant 2003; 18:517-23.
18. Caetano ER, Zatz R, Saldhana LB, Praxeded JN. Hypertensive nephrosclerosis as a relevant cause of chronic renal failure. Hypertension 2001; 38:171-6.
19. Takebayeshi S, Kiyoshi y, Uesugi N, Sasatomi Y, Meng J, Sakata N. Benign nephrosclerosis: Incidence, morphology and prognosis. Clin Nephrol 2001; 55:349-56.
20. Fogo A, Breyer JA, Smith MC, Cleveland WH, Agodoa L, Kirk KA, Glassock R. Accuracy of the diagnosis of hypertensive nephrosclerosis in African Americans: A report from the the African American Study of Kidney Disease (AASK) trial. AASK Pilot Study Investigators. Kidney Int 1997; 51:244-52.
21. Wehrmann M, Bohle A. The long-term prognosis of benign nephrosclerosis accompanied by focal glomerulosclerosis and renal cortical interstitial fibrosis, designated so-called decompensated benign nephrosclerosis by Fahr, Bohle and Ratscheck. Pathol Res Pract 1998; 194:571-6.
22. Churgh J, Sobin LH. Benign nephrosclerosis. In: Churgh J, ed. Renal Disease - Classification and Atlas of Glomerular Diseases. Tokyo, Igaku-Shoin, 1982:211-24.
23. Luke RG. Hypertensive nephrosclerosis: Pathogenesis and prevalence. Essential hypertension is an important cause of end-stage renal disease. Nephrol Dial Transplant 1999; 14:2271-8.
24. Zucchelli P, Zucala A. The diagnostic dilemma of hypertensive nephrosclerosis: The nephrologist's view. Am J Kidney Dis 1993; 21(suppl. 2):87-91.
25. Schlessinger SD, Tankersley MR, Curtis JJ. Clinical documentation of end stage renal disease due to hypertension. Am J Kidney Dis 1994; 23:655-60.
26. Toto RD. Proteinuria and hypertensive nephrosclerosis in African Americans. Kidney Int Suppl 2004; 92:S102-4.
27. Whelton PK, Perneger TV, Brancati FL, Klag MJ. Epidemiology and prevention of blood pressure-related kidney disease. J Hypertens 1992; 10(suppl. 7):S77-84.
28. Go AS, Chertow, GM, Fan D, McCulloch CE, Hsu CY. Chronic Kidney Disease and the Risks of Death, Cardiovascular Events, and Hospitalization. N Engl J Med 2004; 351:1296-305.
29. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 1998; 32:S112-19.
30. Raine AEG. Hypertension and the kidney. Br Med Bull 1994; 50:322-41.